HomeGENX • CVE
add
Genix Pharmaceuticals Corp
Previous close
$0.065
Year range
$0.025 - $0.090
Market cap
3.85M CAD
Avg Volume
2.71K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Revenue | 999.00 | -62.75% |
Operating expense | 41.42K | -74.18% |
Net income | -82.17K | 49.93% |
Net profit margin | -8.23K | -34.44% |
Earnings per share | — | — |
EBITDA | 94.86K | 525.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.23K | 141.49% |
Total assets | 232.78K | -93.94% |
Total liabilities | 1.60M | 25.91% |
Total equity | -1.36M | — |
Shares outstanding | 59.22M | — |
Price to book | -3.25 | — |
Return on assets | -42.47% | — |
Return on capital | 16.36% | — |
Cash Flow
Net change in cash
| (CAD) | Jul 2024info | Y/Y change |
|---|---|---|
Net income | -82.17K | 49.93% |
Cash from operations | -45.93K | 13.07% |
Cash from investing | — | — |
Cash from financing | 46.62K | 178.95% |
Net change in cash | 686.00 | 101.90% |
Free cash flow | -41.32K | -1,161.91% |
About
Founded
1993
Headquarters
Website
